We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.60 | 9.40 | 9.80 | 9.60 | 9.38 | 9.60 | 148,854 | 08:00:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.44 | 89.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/8/2017 12:06 | Lets remind us ... of the basket of Tosh . My current losses on NIPT, are far outweighed by the profits on various other shares. In fact NIPT isn't my worst performer, i have a couple that are even more out of the money, but as i said, a balanced portfolio allows you the ability to ride storms, as what you are potentially losing on one hand, is being more than made up for on the other... Its basic stuff, """" I also have some complete nightmares as well... NYO and DCP hurt """" so just work the maths out on that statement what you are potentially losing on one hand, is being more than made up for on the other... Its basic stuff, 2-2= 0 | inanaco | |
23/8/2017 12:01 | so everyone is an idiot that didn't follow tosh ......... according to the main man Tosh ... | inanaco | |
23/8/2017 11:59 | If you dig long enough you find the pig in the room issue is the other pigs could be turned around ... wonder what they are ... the words of Tosh """" I also have some complete nightmares as well... NYO and DCP hurt """" Appointment of Administrators | inanaco | |
23/8/2017 11:53 | Once again,*WE* are 'treated' to a 'clear indication' that certain CRUDE people are not 'blessed' in grasping what IS written, NEVER MIND, What is intentionally NOT written. | the real lozan | |
23/8/2017 11:53 | Lozan.... if we ignore the idiot, he will hopefully just wither away. Straight away he is trawling back through past posts to try and get a reaction and instigate an argument... I have no interest in the clown anymore. He has proven himself to be a Liar amongst many other things ( none of which are very flattering ), so " job done " , i now have no reason to engage... lets just ignore the pathetic little man. | tosh123 | |
23/8/2017 11:47 | Lozan ... its a stock market, its what people do ... buy and sell, up and down, I hope you have this much concern for every stock ... | inanaco | |
23/8/2017 11:42 | Whereas, there sureleee CAN be NO ONE who is not pleased to see an upturn in share price here Everyone should wish that this does not turn into yet another 'kick-in-the-nuts' for shareholders. One CAN but hope. | the real lozan | |
23/8/2017 11:36 | Blimey - I'm only down 59% now after 5 years! | skinny | |
23/8/2017 11:32 | So Tosh Now compare that to SCLP's pile of cr4p ???????????????? | inanaco | |
23/8/2017 11:31 | Loz ... elbow in ... because I can, and you cannot .. LOL | inanaco | |
23/8/2017 11:30 | tosh i am not AWOL ... tosh123 - 17 May 2017 - 09:07:08 - 9354 of 10884 Using immunology to fight cancer. - SCLP IMM rocking and rolling this morning after another update on the current trial. Thats how a baby bio should be run. Clear news on a regular basis. Clear goals with a clear pathway to achievement. Shareholders treated with respect. Open honest and candid management... Now compare that to SCLP's pile of cr4p. -------------------- but take IMM the share 5 years ago was about 60p before scancell broke cover | inanaco | |
23/8/2017 11:28 | If there is a case for " debate what ? on the LSE, can you show me any debate ?" meaning = there is NOTHING to debate or worth ... Then - WHY have YOU made a few attempts to 'elbow-in' ??? Attempts that , as *WE* see have been met with the COLD SHOULDER from the now AWARE OF YOU users of ELSIE S Central... with whom YOU are trying to 'engage'... and they .... Throw YOU a deaf un ??? | the real lozan | |
23/8/2017 11:26 | Can't read most posts on here - page after page of 'filtered' messages, so apologies if going over old ground. I assume the company must know of something going on, or they'd have had to issue a 'we know of no reason' notice for a climb like this in such a short time? Not sure of what the rules are on responding to sharp falls and rises. Is a partnership deal in the offing? | supernumerary | |
23/8/2017 11:26 | tosh123 - 06 Jun 2017 - 16:18:25 - 9467 of 10884 Using immunology to fight cancer. - SCLP Looks like today might be the day ! Single figures on their way unfortunately, as predicted by some of us. Just watch the sheep try to justify their stance now, and see how they will try to discredit those who called this right yet again... When will they ever learn... and GF must be bricking it, if indeed he does hold what he says he does, which i very much doubt. This is now officially a total shambles, the BOD should be ashamed of themselves, especially RG who said that this was the most successful cash raise ever , what a clown ! When / if this breaks 8p, i might buy some more, but lets see what happens, where it goes and how fast it gets there etc. BOD need to take action now as the 10p threshold is significant. Big error ...... LOL | inanaco | |
23/8/2017 11:25 | A0469514... As i said, both forums are 100% better with the absence of the village idiot. I have no interest in engaging the LIAR anymore... So the best thing to do now that he has been exposed, is to ignore him, my work is done as far as he's concerned. | tosh123 | |
23/8/2017 11:24 | Mr Guff - "A 'bit' of hype is OK, IF it is 'natural enthusiasm' and GENUINE"A bit of scepticism is ok too, if it doesn't become repetitive negative dogma. Repetition of the point "it needs funding" without offering any price at which the stock becomes attractive, constitutes such dogma. I hope nobody locked in losses at the lows, or were dissuaded from buying at the lows, as a result of such posts. | wigwammer | |
23/8/2017 11:13 | Tosh debate what ? on the LSE, can you show me any debate ? the only opinion you have given is just the same old repeat ... | inanaco | |
23/8/2017 11:08 | A0469514... and there in lies a tale. As with C7's forum on the other place, the absence of a certain village idiot means that normal people can debate and exchange views without his destructive and uneducated LIES taking centre stage. I welcome his absence with open arms, long may it continue. | tosh123 | |
23/8/2017 11:07 | Does it make any difference Tosh for you, you have already said you would not buy in at 10p Loz have you dipped your toe in yet ? or you still waiting the funding ? | inanaco | |
23/8/2017 10:34 | J777J, which then begs the question, after 4 - 5 years, " why no deal " ? Not being negative , but it is a question that many people ponder over. If the industry is gushing with cash, and the potential market is in excess of $200 bill, and Scancells science is so nailed on, it beggars belief that RG has not managed to strike a deal. | tosh123 | |
23/8/2017 10:28 | A minnow in an industry gushing with cash.Panmure's albeit conservative 58p odd price target has factored some of that in. | j777j | |
23/8/2017 10:27 | J777J, IMHO, the use of the word " will " is a tad presumptuous. None of us know for sure whether this will ever get to the stage where it is a recommended and prescribed treatment. There are still far too many unknowns at this stage. Of course, if your statement was a nailed on certainty, then the share price would reflect that fact, but as is evident, 13p indicates and reinforces the fact that there is still a lot of work to be done before we can relax. As for Panmures target price, i would take any brokers price as a thing of myth. They have a vested interest to come up with a healthy looking target price, and in most cases, they are wildly inaccurate. Just my thoughts though, others will no doubt have their own very plausible and differing views. | tosh123 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions